Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MDXH | US
-0.06
-1.81%
Healthcare
Diagnostics & Research
30/06/2024
12/03/2026
3.25
3.29
3.40
3.23
MDxHealth SA a commercial-stage precision diagnostics company provides urologic solutions in the United States Europe and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx a non-invasive urine test; and ConfirmMDx an epigenetic test which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal Belgium.
View LessLow Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
34.2%1 month
35.7%3 months
54.0%6 months
62.5%-
-
3.55
-6.43
0.43
-2.73
1.61
-
-18.62M
153.69M
153.69M
-
-32.38
-
32.30
-457.29
0.34
0.11
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.55
Range1M
0.60
Range3M
1.34
Rel. volume
0.60
Price X volume
219.66K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Common Stock | PROF | Diagnostics & Research | 5.55 | 136.41M | -1.07% | n/a | 0.00% |
| Common Stock | BNGO | Diagnostics & Research | 1.12 | 96.32M | -2.61% | 0.03 | 34.32% |
| Anixa Biosciences Inc | ANIX | Diagnostics & Research | 2.86 | 92.03M | -2.72% | n/a | 1.09% |
| Co-Diagnostics Inc | CODX | Diagnostics & Research | 2.63 | 83.93M | -18.83% | n/a | 3.57% |
| Sera Prognostics Inc. | SERA | Diagnostics & Research | 1.99 | 66.40M | 3.11% | n/a | 2.27% |
| ENDRA Life Sciences Inc | NDRA | Diagnostics & Research | 3.27 | 60.13M | -3.25% | n/a | 3.13% |
| Precipio Inc | PRPO | Diagnostics & Research | 28.775 | 42.65M | 2.88% | n/a | 9.66% |
| Cytosorbents Corporation | CTSO | Diagnostics & Research | 0.7257 | 39.50M | 0.10% | n/a | 159.92% |
| BioTelemetry Inc | BEAT | Diagnostics & Research | 1.47 | 39.05M | 8.09% | n/a | 0.00% |
| Neuronetics Inc | STIM | Diagnostics & Research | 1.27 | 38.48M | -1.55% | n/a | 323.03% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 9.5 | 152.54M | -7.90% | n/a | 286.96% |
| Cosmos Group Holdings Inc | COSG | Media - Diversified | 0.0611 | 140.10M | -32.11% | n/a | -91.95% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.31 | 102.79M | 0.96% | 9.09 | 39.79% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 35.62 | 102.29M | -13.08% | 5.16 | 19.82% |
| Reading International Inc | RDIB | Media - Diversified | 10.55 | 82.76M | -4.87% | n/a | 4054.78% |
| ILAG | ILAG | Building Products & Equipment | 2.25 | 40.64M | -14.12% | n/a | 5.48% |
| Reading International Inc | RDI | Media - Diversified | 1.1 | 31.05M | -2.65% | n/a | 4054.78% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.05 | 29.96M | -8.07% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.5643 | 10.90M | -3.54% | n/a | 58.43% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.3953 | 3.76M | 18.11% | n/a | 19.98% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.73 | 12.67 | Cheaper |
| Ent. to Revenue | 1.61 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 3.55 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 54.02 | 59.59 | Par |
| Debt to Equity | -6.43 | -14.36 | Expensive |
| Debt to Assets | 0.43 | 0.34 | Expensive |
| Market Cap | 153.69M | 13.71B | Emerging |